Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akio Matsubara

Showing results (141-150 of 191) with videos related to

Pageof 20
Sort By:
Oncology Letters|July 12, 2014
Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapyJun Teishima, Kohei Kobatake, Tetsutaro Hayashi, et al.
Virchows Archiv : an International Journal of Pathology|November 29, 2021
Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinomaGo Kobayashi, Tetsutaro Hayashi, Kazuhiro Sentani, et al.
BMC Cancer|October 11, 2015
Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in JapanMasatoshi Eto, Yoshiaki Kawano, Yoshihiko Hirao, et al.
IJU Case Reports|August 4, 2020
Refractory fistula of bladder repaired with transurethral cystoscopic injection of <i>N</i>-butyl-2-cyanoacrylateSakurako Mukai, Shunsuke Shinmei, Masayuki Muto, et al.
BJU International|August 26, 2015
The impact of change in serum C-reactive protein level on the prediction of effects of molecular targeted therapy in patients with metastatic renal cell carcinomaJun Teishima, Kohei Kobatake, Hiroyuki Kitano, et al.
Anticancer Research|April 3, 2020
PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell CarcinomaYohei Sekino, Takeshi Hagura, Xiangrui Han, et al.
Plos Biology|April 17, 2014
A novel protein, CHRONO, functions as a core component of the mammalian circadian clockAkihiro Goriki, Fumiyuki Hatanaka, Jihwan Myung, et al.
Cancer Medicine|July 9, 2021
Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancerTakashi Babasaki, Kazuhiro Sentani, Yohei Sekino, et al.
Abdominal Radiology (New York)|May 26, 2018
Tubulocystic renal cell carcinoma: a review of literature focused on radiological findings for differential diagnosisYukiko Honda, Yuko Nakamura, Keisuke Goto, et al.
BMC Cancer|October 6, 2018
Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinomaYohei Sekino, Naoya Sakamoto, Keisuke Goto, et al.
Pageof 20

Showing results (141-150 of 191) with videos related to

Sort By:
Pageof 20
Oncology Letters|July 12, 2014
Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapyJun Teishima, Kohei Kobatake, Tetsutaro Hayashi, et al.
Virchows Archiv : an International Journal of Pathology|November 29, 2021
Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinomaGo Kobayashi, Tetsutaro Hayashi, Kazuhiro Sentani, et al.
BMC Cancer|October 11, 2015
Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in JapanMasatoshi Eto, Yoshiaki Kawano, Yoshihiko Hirao, et al.
IJU Case Reports|August 4, 2020
Refractory fistula of bladder repaired with transurethral cystoscopic injection of <i>N</i>-butyl-2-cyanoacrylateSakurako Mukai, Shunsuke Shinmei, Masayuki Muto, et al.
BJU International|August 26, 2015
The impact of change in serum C-reactive protein level on the prediction of effects of molecular targeted therapy in patients with metastatic renal cell carcinomaJun Teishima, Kohei Kobatake, Hiroyuki Kitano, et al.
Anticancer Research|April 3, 2020
PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell CarcinomaYohei Sekino, Takeshi Hagura, Xiangrui Han, et al.
Plos Biology|April 17, 2014
A novel protein, CHRONO, functions as a core component of the mammalian circadian clockAkihiro Goriki, Fumiyuki Hatanaka, Jihwan Myung, et al.
Cancer Medicine|July 9, 2021
Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancerTakashi Babasaki, Kazuhiro Sentani, Yohei Sekino, et al.
Abdominal Radiology (New York)|May 26, 2018
Tubulocystic renal cell carcinoma: a review of literature focused on radiological findings for differential diagnosisYukiko Honda, Yuko Nakamura, Keisuke Goto, et al.
BMC Cancer|October 6, 2018
Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinomaYohei Sekino, Naoya Sakamoto, Keisuke Goto, et al.
Pageof 20